Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium
- 30 September 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (3) , 684-689
- https://doi.org/10.1016/0735-1097(93)90177-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Platelets Enhance Anoxic Contraction of Rat Aortic Rings Through Platelet-Activating Factor-Dependent MechanismJournal of Cardiovascular Pharmacology, 1993
- Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevanceJournal of the American College of Cardiology, 1990
- Platelet activation in unstable angina: Role of thromboxane A2 and other mediators of vasoconstrictionJournal of the American College of Cardiology, 1990
- Aspirin in myocardial ischemia: Why, when, and how much?Clinical Cardiology, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Platelets, endothelium, and vasospasm.Circulation, 1985
- Inhibitory Role of the Endothelium in the Response of Isolated Coronary Arteries to PlateletsScience, 1983
- Verapamil therapy for unstable angina pectoris: Review of double-blind placebo-controlled randomized clinical trialsThe American Journal of Cardiology, 1982
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979